Are Nonclinical factors important for the Health Technology Assessment (HTA) processes? If yes, for who?
Traditionally, value assessment of new medicines and technology products is mostly based on the benefits and impact that these bring in terms of clinical efficacy, safety, and costs. However, there is an emerging discussion...